NMD4C and MDC Host Second SMA Outcome Measure Training Workshop for Physiotherapists and Occupational Therapists Across Canada

NMD4C and MDC Host Second SMA Outcome Measure Training Workshop for Physiotherapists and Occupational Therapists Across Canada

The Spinal Muscular Atrophy (SMA) Motor Function Measures workshop organized by the NMD4C in collaboration with MDC took place in Montreal, Quebec on December 3rd, 2024 and was a resounding success. This workshop was established to harmonize assessment practices for the following SMA outcome measures across Canada:

  • Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders
  • Bayley’s Scale of Infant & Toddler Development
  • Adapted Test of Neuromuscular Disorders
  • Hammersmith Motor Functional Scale – Expanded
  • Revised Upper Limb Module
  • 6 Minute Walk Test
  • Patient Reported Outcome Measures for SMA

The workshop complemented the interactive training session that took place earlier this year for French-speaking physiotherapists and occupational therapists in Quebec City. This initiative was created to deliver essential training to clinicians (physiotherapists and occupational therapists), ensuring a consistent approach to evaluating motor function in children and adults with SMA.

Workshop developers Dr. Cam-Tu Émilie Nguyen, Sarah Turgeon-Desilets, Melissa Dermody, Angela Chiu, Cheryl Scholtes, Allison Banks & Dorothy Drost

Content co-designed and co-developed by (L to R) Dr. Cam-Tu Émilie Nguyen, Sarah Turgeon-Desilets, Melissa Dermody, Angela Chiu, Cheryl Scholtes, Allison Banks & Dorothy Drost

Therapists from the following provinces were in attendance: Ontario, Quebec, Alberta, British Columbia, New Brunswick, Nova Scotia, Saskatchewan & Manitoba. Post-event surveys reinforced that the participants highly valued the opportunity to attend in-person training, to network with colleagues across Canada, engage in productive discussions on outcome measures for SMA and gain knowledge on establishing a clinic for the adult SMA population. The workshop also featured insights from a patient partner with lived experience – Catherine Boivin, who shared her experiences with the outcome measure assessments.

A report summarizing both the French and English workshops is currently in creation and will be available soon. The content from this SMA outcome measures workshop will be used to create an online interactive training resource to provide access to this cutting-edge training to a broader audience.

If you are interested in receiving training resources, or to learn more about our work on outcome measures, please contact NMD4C Outcome Measures and Natural History Coordinator Zainab Adamji to learn how we can work together.

NMD4C and MDC Host Second SMA Outcome Measure Training Workshop for Physiotherapists and Occupational Therapists Across Canada

Read next...

CPNG 2026

Zolgensma® Safety Update and CPNG Guidance for Families

The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.